Artwork

Content provided by Meet Global @Business Next Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Meet Global @Business Next Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S2E4: CancerFree Develops Personalised Cancer Cell Profile And Won Investment From Tim Draper

35:11
 
Share
 

Manage episode 381097485 series 3424472
Content provided by Meet Global @Business Next Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Meet Global @Business Next Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Have you ever considered the possibility that a loved one of yours has cancer? If you were in that circumstance, how would you respond? Before his father's initial cancer diagnosis in 2015 and the subsequent three cancer diagnoses, Po Chen worked as the head of the IT security division at Morgan Stanley Financial in the US. He learned that his father's treatment plan was difficult and that he would need to undergo chemotherapy and repeatedly try various pharmaceutical injections for each ailment when he went with him to the hospital. Po Chen decided to leave his job in the US to enter the field of biomedical innovation, embarking on an entrepreneurial journey in Taiwan to improve cancer care.
We are honoured to have Po Chen, the CEO and Founder of CancerFree, joins us on this episode to discuss how the company developed the first commercial Circulating Tumour Cell-Derived Organoid culture system in the world as part of its EVA technology platform, which has superior efficacy, efficiency, and speed to other technologies currently on the market. And the aspiration to follow in the footsteps of all cancer patients by becoming a reliable confidante of healthcare providers.
In this episode of Startup Island Taiwan Podcast, you will find out:
☛ Po’s inspiration of his entrepreneurship came from the sickness of his father
☛ The Taipei Medical University provided the original technology
☛ In the medical technology sector, research serves as promotional content
☛ CancerFree will collect US medical data with an automated facility in New York during the next 12 to 24 months
☛ The goal is to create a comprehensive intern training programme at CancerFree, akin to what Google and Morgan Stanley do
Host: Asianometry, deep tech channel with 563k followers, still growing
Guest: Po Chen, CEO & Founder of CancerFree
Powered by Startup Island TAIWAN
Directed by National Development Council
Produced by Meet Global by Business Next Media
👉More news of Taiwan startups: https://meetstartup.pse.is/4jhd5u
👉Follow us on LinkedIn: https://meetstartup.pse.is/4hhbhg
📪 Email us: global@bnext.com.tw
Leave a comment and share your thoughts: https://open.firstory.me/user/cl8jubp5t01v601sl4vys57dj/comments


Powered by Firstory Hosting
  continue reading

59 episodes

Artwork
iconShare
 
Manage episode 381097485 series 3424472
Content provided by Meet Global @Business Next Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Meet Global @Business Next Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Have you ever considered the possibility that a loved one of yours has cancer? If you were in that circumstance, how would you respond? Before his father's initial cancer diagnosis in 2015 and the subsequent three cancer diagnoses, Po Chen worked as the head of the IT security division at Morgan Stanley Financial in the US. He learned that his father's treatment plan was difficult and that he would need to undergo chemotherapy and repeatedly try various pharmaceutical injections for each ailment when he went with him to the hospital. Po Chen decided to leave his job in the US to enter the field of biomedical innovation, embarking on an entrepreneurial journey in Taiwan to improve cancer care.
We are honoured to have Po Chen, the CEO and Founder of CancerFree, joins us on this episode to discuss how the company developed the first commercial Circulating Tumour Cell-Derived Organoid culture system in the world as part of its EVA technology platform, which has superior efficacy, efficiency, and speed to other technologies currently on the market. And the aspiration to follow in the footsteps of all cancer patients by becoming a reliable confidante of healthcare providers.
In this episode of Startup Island Taiwan Podcast, you will find out:
☛ Po’s inspiration of his entrepreneurship came from the sickness of his father
☛ The Taipei Medical University provided the original technology
☛ In the medical technology sector, research serves as promotional content
☛ CancerFree will collect US medical data with an automated facility in New York during the next 12 to 24 months
☛ The goal is to create a comprehensive intern training programme at CancerFree, akin to what Google and Morgan Stanley do
Host: Asianometry, deep tech channel with 563k followers, still growing
Guest: Po Chen, CEO & Founder of CancerFree
Powered by Startup Island TAIWAN
Directed by National Development Council
Produced by Meet Global by Business Next Media
👉More news of Taiwan startups: https://meetstartup.pse.is/4jhd5u
👉Follow us on LinkedIn: https://meetstartup.pse.is/4hhbhg
📪 Email us: global@bnext.com.tw
Leave a comment and share your thoughts: https://open.firstory.me/user/cl8jubp5t01v601sl4vys57dj/comments


Powered by Firstory Hosting
  continue reading

59 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide